Please use this identifier to cite or link to this item: https://doi.org/10.1002/hup.1068
DC FieldValue
dc.titleOpioid use affects antioxidant activity and purine metabolism: Preliminary results
dc.contributor.authorMannelli, P.
dc.contributor.authorPatkar, A.
dc.contributor.authorRozen, S.
dc.contributor.authorMatson, W.
dc.contributor.authorKrishnan, R.
dc.contributor.authorKaddurah-Daouk, R.
dc.date.accessioned2014-11-26T09:04:53Z
dc.date.available2014-11-26T09:04:53Z
dc.date.issued2009
dc.identifier.citationMannelli, P., Patkar, A., Rozen, S., Matson, W., Krishnan, R., Kaddurah-Daouk, R. (2009). Opioid use affects antioxidant activity and purine metabolism: Preliminary results. Human Psychopharmacology 24 (8) : 666-675. ScholarBank@NUS Repository. https://doi.org/10.1002/hup.1068
dc.identifier.issn08856222
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110602
dc.description.abstractObjective: More must be learned about metabolic and biochemical alterations that contribute to the development and expression of drug dependence. Experimental opioid administration influences mechanisms and indices of oxidative stress, such as antioxidant compounds and purine metabolism. We examined perturbations of neurotransmitter-related pathways in opioid dependence (OD). Methods: In this preliminary study, we used a targeted metabolomics platform to explore whether biochemical changes were associated with OD by comparing OD individuals (n = 14) and non-drug users (n = 10). Results: OD patients undergoing short-term methadone detoxification showed altered oxidation-reduction activity, as confirmed by higher plasma levels of α- and γ- tocopherol and increased GSH/GSSG ratio. OD individuals had also altered purine metabolism, showing increased concentration of guanine and xanthosine, with decreased guanosine, hypoxanthine and hypoxanthine/xanthine and xanthine/xanthosine ratios. Other drug use in addition to opioids was associated with partly different biochemical changes. Conclusions: This is a preliminary investigation using metabolomics and showing multiple peripheral alterations of metabolic pathways in OD. Further studies should explore the metabolic profile of conditions of opioid abuse, withdrawal and long-term abstinence in relation to agonist and antagonist treatment and investigate biochemical signatures of opioid substances and medications. Copyright © 2009 John Wiley & Sons, Ltd.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1002/hup.1068
dc.sourceScopus
dc.subjectAddiction
dc.subjectMetabolic profiling
dc.subjectMetabolomics
dc.subjectMetabonomics
dc.subjectMethadone
dc.subjectOpioid detoxification
dc.typeArticle
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1002/hup.1068
dc.description.sourcetitleHuman Psychopharmacology
dc.description.volume24
dc.description.issue8
dc.description.page666-675
dc.description.codenHUPSE
dc.identifier.isiut000273189200007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.